Non-human immunodeficiency virus-related Kaposi's sarcoma of the oropharynx: a case report and review of the literature. by Crosetti, E & Succo, G
JOURNAL OF MEDICAL
CASE REPORTS
Crosetti and Succo Journal of Medical Case Reports 2013, 7:293
http://www.jmedicalcasereports.com/content/7/1/293CASE REPORT Open AccessNon-human immunodeficiency virus-related
Kaposi’s sarcoma of the oropharynx: a case report
and review of the literature
Erika Crosetti1* and Giovanni Succo2Abstract
Introduction: Kaposi’s sarcoma is a malignant, slowly progressing, mesenchymal neoplasm characterized by a
proliferation of connective tissue and capillaries. Clinical presentation is usually as nodules and red-purple plaques.
This case report not only represents an uncommon presentation of Kaposi’s sarcoma in a non-immunocompromised
patient, but also supports the role of viral infection in the pathogenesis of this disease. It provides some interesting
information about this rare disease, particularly in patients who are human immunodeficiency virus negative.
Case presentation: A 48-year-old Caucasian man presented with a sensation of a foreign body in his throat,
accompanied by stomatolalia. Maxillofacial and neck magnetic resonance imaging confirmed the presence of a
voluminous solid mass at the base of his tongue with oropharyngeal space reduction. Histological analysis indicated
that the lesion was compatible with ulcerated Kaposi’s sarcoma of the oropharynx. Results of serological tests for
human immunodeficiency virus infection were negative as was the result of the human herpesvirus-8 test, but
the cytomegalovirus test result was positive.
Conclusions: This case is unusual because the patient had only oropharyngeal localization of disease, without
evidence of immunosuppression or the typical background or risk factors suggesting the classic or endemic form of
Kaposi’s sarcoma. Isolated cases of Kaposi’s sarcoma with oropharyngeal manifestations not associated with human
immunodeficiency virus infection are rare, and only 15 cases have been reported to date. At present, its localization,
microscopic and histological characteristics, and patterns of progression are the main tools used for differential
diagnosis of Kaposi’s sarcoma from other vascular neoplasms.
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Kaposi’s sarcoma, the most common neoplasm associated
with acquired immunodeficiency syndrome (AIDS), is a
malignant, slowly progressing, mesenchymal neoplasm
characterized by proliferation of connective tissue and
capillaries. Clinical presentation is usually as nodules
and red-purple plaques [1]. Here we present a case of
Kaposi’s sarcoma of the oropharynx that was unrelated to
human immunodeficiency virus (HIV) infection. Isolated
cases of Kaposi’s sarcoma with oropharyngeal manifes-
tations not associated with HIV infection are rare, and
only 15 cases have been reported to date [2,3].* Correspondence: erikacro73@yahoo.com
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A 48-year-old Caucasian man presented to our department
referring the sensation of a foreign body in his throat,
accompanied by stomatolalia. His family came from
Sardinia. The man, a clerk, did not smoke and drank only
socially. He was otherwise in good general health. An
endoscopic examination showed the presence of a volu-
minous red-purple lesion at the base of his tongue, mobile,
and reducing his oropharyngeal airway. Maxillofacial and
neck magnetic resonance imaging confirmed the presence
of a voluminous solid mass at the base of his tongue with
oropharyngeal space reduction (Figures 1 and 2). He was
subjected to direct microlaryngoscopy and carbon dioxide
(CO2) laser excision of the mass. The surgical margins
were negative. Histological analysis indicated that the
lesion was compatible with ulcerated Kaposi’s sarcoma ofentral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
Figure 1 Maxillofacial and neck magnetic resonance imaging
(axial view): presence of a voluminous solid mass at the base
of the tongue with oropharyngeal space reduction.
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The patient was married, had regular sexual activity with
his wife and reported that he did not practice oral sex.
He also denied any intravenous drug abuse and he had
never received immunosuppressive therapy. The resultsFigure 2 Maxillofacial and neck magnetic resonance imaging
(sagittal view): voluminous mass at the base of the tongue.of serological tests for HIV were negative, and the patient
also underwent dermatological examination. Clinical and
radiological examination did not reveal any other localiza-
tions of disease. The human herpesvirus-8 (HHV8) test
result was negative, but the cytomegalovirus test result
was positive. He has undergone regular follow-up and
is disease-free at the present time.
Discussion
Kaposi’s sarcoma was described for the first time in 1872
by Moritz Kaposi using the term “multiple idiopathic
hemorrhagic sarcoma” [1]. This disease is characterized
by a variety of clinical and histological patterns. It is a
malignant neoplasm that follows an indolent and usually
protracted course. Kaposi’s sarcoma is generally classified
into four forms [2-5]: classic or endemic; African; epidemic;
or associated with renal transplantation.
The classic or endemic form usually affects males (male
to female ratio is 15:1) who live in Mediterranean countries
with a peak incidence between 50 and 70 years of age.
Clinically, macular lesions are observed at the level of the
trunk and inferior limbs, with a tendency to manifest
as nodules and plaques. This form generally has a long
clinical course (10 to 15 years) with slow progression,
and patients often die of other causes. Its localization
in the oral cavity and oropharynx is rare and occurs
late in the course of disease [2,3]. In a review in 1975,
Farman and Uys [6] identified 50 patients with an endoral
localization of Kaposi’s sarcoma. These patients had the
classic form of the disease, although diagnostic criteria
were cutaneous localizations on the lower limbs.
The African form is typical in the central regions of
Africa, and most frequently affects males between 25
and 40 years of age. Clinically, two subtypes have been
identified [5]: a less aggressive type, characterized by the
presence of plaques and cutaneous nodules with slow
progression similar to the classic form and a more
aggressive variety, which typically manifests in pediatric
patients, in which there is visceral and lymph node
involvement, in addition to classic cutaneous and mucosal
lesions. This form has an extremely poor prognosis and
patients usually die of gastrointestinal hemorrhage within
2 to 3 years after diagnosis. Oral and oropharyngeal
localizations of the disease are rare in both subtypes of
the African form [5].
The epidemic form is typical in patients with AIDS, and
represents about 90% of malignant neoplasms diagnosed
in these individuals. On clinical examination, the epidemic
form is characterized by the appearance of disseminated
mucocutaneous lesions associated with visceral and lymph
node involvement. Localizations in the oral cavity and
oropharynx are frequent and often represent the first
symptom of disease. The clinical course of this form is
dismal, as patients die quickly either from progression
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immunodeficiency [5-7].
In 1991, Chockley and Coke [8] reported that, in
patients with AIDS and Kaposi’s sarcoma, the presence
of localizations in the oral cavity and oropharynx were
probably associated with progression of disease. In 77% of
cases, localizations were observed on the palate, on the
gums in 36%, and on the dorsal surface of the tongue
in 15%. The gingival mucous and lips are less frequently
involved. Such lesions, initially asymptomatic, can become
ulcerous and painful.
The form of Kaposi’s sarcoma associated with renal
transplantation has an incidence of 0.4% in the USA. The
clinical course shows slow progression, but can be rapidly
fatal in some cases due to massive visceral involvement.
The extent of disease is directly proportional to the degree
of immunodeficiency. Localizations in the oral cavity or
oropharynx are rare in this subtype [4,9].
On histological examination, Kaposi’s sarcoma is charac-
terized by a rich cellular component without atypia and
with vascular lacunae. The stroma, in which blood vessels
are present, is rich in extravasated erythrocytes and hemo-
siderin deposits. The four clinical forms of the disease
present with nearly identical histological characteristics [9].
This case is unusual because our patient had only
oropharyngeal localization of disease, without evidence
of immunosuppression or the typical background or risk
factors suggesting the classic or endemic form of Kaposi’s
sarcoma. In other cases described in the literature,
the lesions generally were localized on the posterior
wall of the pharynx and were small. In our case, the
imaging showed the presence of a voluminous solid
mass at the base of the tongue with oropharyngeal
space reduction [2,3].
The etiology of Kaposi’s sarcoma is still widely debated,
although a viral origin is the most commonly accepted
hypothesis at present. According to some authors [10,11],
Kaposi’s sarcoma is not a true neoplasm, but rather a
hyperplastic reaction caused by angiogenetic factors
released from either CD4+ lymphocytes or viruses. Recent
studies have shown that there is a close correlation
between Kaposi’s sarcoma and HHV8. In particular, the
presence of genomic HHV8 deoxyribonucleic acid (DNA)
is a diagnostic tool for differentiating this neoplasm from
other vascular tumors, such as hemangioendothelioma,
kaposiform hemangioendothelioma, angiosarcoma, fibro-
sarcoma, and arteriovenous malformations [12,13].
In 1998, Hisaoka et al. [14] evaluated 93 cases of benign
and malignant vascular lesions. All patients had a diagnosis
of Kaposi’s sarcoma and all were positive for HHV8. More
recently, the identification of HHV8 as a possible etiologic
factor has suggested the potential efficacy of antiviral agents
such as protease inhibitors in the treatment of Kaposi’s
sarcoma. In 1998, Benfield et al. [15] described threecases of Kaposi’s sarcoma in complete remission after
administration of protease inhibitors.
In our patient, the result of the HHV8 test was negative,
but the result of the cytomegalovirus test was positive. In
the literature, there is good evidence that cytomegalovirus
could play a role in the pathogenesis of this disease. DNA
from the virus has been localized to the tumor cells of
Kaposi’s sarcoma by in situ hybridization methods, in
non-HIV-related Kaposi’s sarcoma cases as well as
those associated with HIV infection [16-20]. The role
of cytomegalovirus in tumorigenesis is accomplished by
the integration of a portion of its DNA into the host
genome and, possibly, by amplification or mutation of
oncogenetic sequences, in keeping with traditional models
of virally induced tumor production [21].
Furthermore, the patient’s family came from Sardinia,
even though he had grown up in the Piedmont region of
Italy. The frequency of classic (non-HIV-related) Kaposi’s
sarcoma is high in Sardinia [22]. Cerimele et al. have
found that the human leukocyte antigen (HLA)-DR5 allele
is greatly overrepresented in Sardinians with Kaposi’s
sarcoma (significance level of P <0.001). By contrast, the
HLA-DR3 allele associated with autoimmune diseases
such as diabetes mellitus, Sjögren’s syndrome, and celiac
sprue [22], is uncommon, compared with the control
population. To add further support to these observations,
other authors have shown that human leukocyte antigen
(HLA)-DR5 is also common in patients who have HIV
with this neoplasm [23]. The absence of the HLA-D3
allele in patients affected by non-HIV-related Kaposi’s
sarcoma may reflect the relative lack of an immune
response as a factor in the pathogenesis of this tumor.
Regarding therapeutic planning, as Kaposi’s sarcoma is
a systemic multifactorial disease, management is based on
symptoms. In general, the majority of patients with non-
HIV-related Kaposi’s sarcoma and oral and/or oropharynx
localization do not require specific treatment if symptoms
such as odynophagia, dysphagia, and hemorrhage at other
sites are not present. There are several treatment options
for patients with the classic form and oral and/or oro-
pharynx localization: CO2 or argon laser to minimize
the possibility of bleeding; radiotherapy, Kaposi’s sarcoma
is relatively radiosensitive, requiring a dose less than
2000 rad; intralesional or systemic chemotherapy with
vinblastine (alone or in combination with other chemo-
therapeutic drugs); topical treatments are generally well
tolerated, inexpensive, and repeatable, thus avoiding
systemic immunosuppression.
This case report not only represents an uncommon
presentation of Kaposi’s sarcoma in a non-immunocom-
promised patient, but also supports the role of viral
infection in the pathogenesis of this disease. Non-HIV-
related Kaposi’s sarcoma is probably caused by a similar
mechanism to AIDS-related Kaposi’s sarcoma, which
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oncogenesis (perhaps linked to the human leukocyte
antigen (HLA)-DR5 locus). Cytomegalovirus probably
plays a role in the development of the disease, in concert,
in most cases, with concomitant immunodeficiency.
Conclusions
Cases of Kaposi’s sarcoma with non-HIV-related oro-
pharyngeal manifestations are rare, and to date only 15
cases have been reported in the literature. At present, its
localization, microscopic and histological characteristics,
and patterns of progression are the main tools used for
differential diagnosis of Kaposi’s sarcoma from other
vascular neoplasms.
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